NIOX Group Plc, a diagnostics and management company, design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Stock data | 2024 | Change |
---|---|---|
Price | $0.874417383312545 | N/A |
Market Cap | $368.05M | N/A |
Shares Outstanding | 420.91M | N/A |
Employees | 92.00 | N/A |